- Clear All
- Remove theAVMA Newsfilter AVMA News
- Remove thePolicyfilter Policy
- Remove theImmunologyfilter Immunology
- Remove theInternal medicinefilter Internal medicine
- Remove theNational legislation & regulationfilter National legislation & regulation
- Remove theVaccinationfilter Vaccination
- Remove theBiosecurityfilter Biosecurity
- Remove theProduction medicinefilter Production medicine
AVMA news
Blood-derived products demystified for equine practitioners
The American Association of Equine Practitioners’ Infectious Disease Committee recently updated the association’s white paper on equine blood, plasma,…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
AVMA news
Georgia professor to join National Academy of Inventors
Dr. Naola Ferguson-Noel, a professor at the University of Georgia College of Veterinary Medicine, is one of 169 scientists and researchers who will be…
AVMA news
Advances in animal genome editing continue apace
The Food and Drug Administration (FDA) recently green lit for human consumption five genetically modified pigs at Washington State University.…
AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
policy
Joint AVMA-FVE-CVMA statement on the benefits of animal vaccination programs in advancing animal and human health
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.